Clinical Trials Directory

Trials / Completed

CompletedNCT03355690

The Care of Stroke in Ziekenhuis Oost-Limburg

The Care of Stroke in the Hospital of Genk: Outcome After Treatment and the Health-economic Impact of Stroke in the Patient Population

Status
Completed
Phase
Study type
Observational
Enrollment
564 (actual)
Sponsor
Ziekenhuis Oost-Limburg · Academic / Other
Sex
All
Age
18 Years – 110 Years
Healthy volunteers
Not accepted

Summary

A stroke occurs when the blood circulation is hampered due an ischemic or hemorrhagic event. Previous, a stroke was treated only with anti-aggregation. Over time, multiple studies have showed a positive effect of intravenous thrombolysis with rt-PA (recombinant tissue plasminogen activator) in comparison with the standard treatment (anti-aggregation). Since 2015, thrombectomy was proven to have an added value in combination with thrombolysis. Thrombectomy is an endovascular technique where the thrombus is removed or fragmented. Diagnosis and treatment of stroke will have a significant impact on the health-economic status of the patient. However, little data is known. Unfortunately, the outcome after diagnosis with a stroke is not well documented. Therefore, this follow-up study over a time period of one year, will give us a sufficient amount of data to evaluate patients diagnosed with a stroke in the hospital of Genk.

Conditions

Timeline

Start date
2017-12-15
Primary completion
2019-12-15
Completion
2019-12-15
First posted
2017-11-28
Last updated
2023-04-18

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT03355690. Inclusion in this directory is not an endorsement.